Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

27%

3 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

Phase 1
3(37.5%)
Phase 4
2(25.0%)
N/A
1(12.5%)
Phase 3
1(12.5%)
Phase 2
1(12.5%)
8Total
Phase 1(3)
Phase 4(2)
N/A(1)
Phase 3(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)